Xantis

Stronger together

Fri, 11 Jan 2019 14:44:00 +0000

Late December 2018, Xantis Pharma acquired IPS (Integrated Pharma Solutions GmbH). We are all excited about the combination of these two companies and convinced that they complement each other - making us a stronger company.

New products in the Russian market

Thu, 09 Nov 2017 13:53:00 +0000

Xantis Pharma launched two new products in Russia in October.

Xantis Pharma acquires Russian pharmaceutical company Alsi Pharma

Wed, 07 Jun 2017 13:48:00 +0000

Xantis Pharma, has acquired Russian pharmaceutical manufacturer Alsi Pharma. Xantis was founded in 2015, by the investment firm Novator and experienced pharmaceutical executives, with the vision of building a fully integrated pharmaceutical company in the markets where it operates, which currently are in Russia, Ukraine, the CIS and Central and Eastern Europe.

Xantis establishes an Executive Committee

Tue, 21 Mar 2017 16:02:00 +0000

Xantis Pharmaceuticals has established a new Executive Committee.

Additions to the Xantis executive team

Wed, 16 Nov 2016 11:14:00 +0000

In the recent months Xantis Pharma has made several significant additions to its executive team working in the Prague office.

Xantis launches SANORIN Aqua NATURA in Czech and Slovakia

Tue, 06 Sep 2016 14:29:00 +0000

Xantis Pharma today launched a new product in Czech and Slovakia; SANORIN Aqua NATURA.

Xantis Pharma acquires portfolio and teams up with Saneca for manufacturing and R&D

Fri, 02 Sep 2016 11:55:00 +0000

Xantis Pharma has acquired more than 20 pharmaceutical products and has signed a five-year manufacturing and development contract with Slovakia-based CDMO Saneca Pharmaceuticals.

Lars Ramneborn joins Xantis Pharma as CEO

Wed, 15 Jun 2016 12:32:00 +0000

Lars Ramneborn has joined Xantis Pharma as CEO. Lars has held leadership roles in Europe’s Pharmaceutical sector for over 25 years. He joined Xantis Pharma from Actavis/Allergan.